Brief: An2 Therapeutics Inc Announces Pricing Of Its Upsized IPO Of 4,600,000 Shares Of Its Common Stock At A Price To Public Of $15.00/Share
March 24 (Reuters) - AN2 Therapeutics Inc ANTX.O :
* AN2 THERAPEUTICS INC - PRICING OF ITS UPSIZED INITIAL
PUBLIC
OFFERING OF 4,600,000 SHARES OF ITS COMMON STOCK AT A PRICE TO
PUBLIC OF $15.00 PER SHARE
Source text for Eikon: ID:nGNX4zgXgC
Further company coverage: ANTX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on AN2 Therapeutics
See all newsBrief: AN2 Therapeutics, Inc. Reports Inducement Grants Under Listing Rule 5635(C)(4)
Brief: An2 Therapeutics Announces Extension Of Funding For Tuberculosis Research Collaboration With Gsk
AN2 Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
AN2 Therapeutics Q2 net loss widens on higher R&D costs
AN2 Therapeutics Inc expected to post a loss of 27 cents a share - Earnings Preview